National Survey of the Impact of COVID-19 Pandemics

Questionnaire Clinical Trial

— CMDA-SURVEY2  

Official title:

National Survey of the Impact of COVID-19 Pandemics on Chinese Physicians of Obstetrics and Gynecology

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04491201
• Other study ID #: CMDA-SURVEY2
• Status: Recruiting
• Start date: July 27, 2020
• Est. completion date: September 27, 2020

Study information

• Verified date: July 2020
• Source: Peking Union Medical College Hospital
• Contact: Lei Li, M.D.
• Phone: 86-139-1198-8831
• Email: lileigh[@]163.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

COVID-19 pandemics have changed extensively the lives around the world. Although most physicians of obstetrics and gynecology have no critical role in the frontline against COVID-19 pandemics, their work, research and education activities still underwent great changes. The primary aim of this study is to analyze change of workload during the COVID-19 pandemics in physicians of obstetrics and gynecology in China. A customized questionnaire will be delivered by the social software WeChat to the specific hospital which has been randomly sampled, and all physicians of Obstetrics and Gynecology in this hospital will fill the questionnaire anonymously.

A random sampling will be performed in all 32 provinces, municipality or autonomous regions in the mainland of China. It is assumed that acceptable 95% confidence interval is P±4%, and the sample size under the condition of simple random sampling is 600 persons. If the homogeneity is set as 0.15 or 0.2, and each population (unit) has 10 or 15 persons accepting survey, we will achieve a design effect of 2.35 to 3.80. If we choose the design effect of 3, the sample size of every level needs is 1800. Considering 10% population refusing to be surveyed, in all mainland of China, three levels of hospitals will include at least 6000 physicians who accept survey.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 6000
• Est. completion date: September 27, 2020
• Est. primary completion date: September 27, 2020
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Aged 18 years old

• Belonging to and registered at specific hospital

• Active employment in obstetrics, reproduction, or gynecology

• Signed an approved informed consents

Exclusion Criteria:

• Not meeting all the inclusion criteria

• Not completing the whole questionnaire

Related Conditions & MeSH terms

• China
• COVID-19 Pandemics
• National Survey
• Obstetrics and Gynecology
• Questionnaire
• Workload

Intervention

Other:
• Customized questionnaire
A customized questionnaire will be delivered by the social software WeChat to the specific hospital which has been randomly sampled, and all physicians of Obstetrics and Gynecology in this hospital will fill the questionnaire anonymously.

Locations

Country	Name	City	State
China	Lei Li	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Lei Li

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The changes of workload of physicians during COVID-19 pandemics compared with 2019 year	Reduction or augment in percentage of workload including outpatient clinics, surgeries, counseling and deliveries	Six months
Secondary	The changes of education activities during COVID-19 pandemics compared with 2019 year	Reduction or augment in percentage of education activities including lectures, ward rounds and exams.	Six months
Secondary	The changes of research activities during COVID-19 pandemics compared with 2019 year	Reduction or augment in percentage of research activities including research protocol advancement, paper composition/submission/publication, and fund application	Six months